The Food and Drug Administration announced plans to hold a summer meeting to consider relaxing restrictions on over a dozen peptide injections, which have gained popularity among wellness advocates, influencers, and some celebrities. The move follows repeated calls from Health Secretary Robert F. Kennedy Jr., who advocates loosening regulations on these substances, citing personal benefits and supporting their use despite limited scientific evidence on safety and efficacy.

Currently, most peptides have not undergone thorough FDA review, raising concerns among health officials and experts about potential safety risks, including cancer and organ damage. The agency plans to consult outside advisers to determine whether these peptides can be safely produced by pharmacies and may soon remove them from a list that classifies high-risk unapproved drugs. Critics argue that relaxing rules could undermine the FDA’s drug approval system, possibly leading to increased market availability of untested and potentially dangerous products, while supporters claim it would improve access and reduce illicit markets.

The issue is entangled with broader debates about supplement regulations, safety, and the influence of wellness culture. While some FDA-approved peptides exist for medical purposes like diabetes and obesity, many marketed online have never been approved, and some are banned in sports. Industry advocates are pushing for expanded ingredient inclusion in supplements, despite safety concerns raised by health professionals and regulatory officials, highlighting a contentious future for peptide regulation in the U.S.